Physician profile
Keyle Brown
NPI 1104209857
$181,799.61
in general payments reported to CMS, 2019-2025
12 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $15K · 2021: $17K · 2022: $35K · 2023: $28K · 2024: $31K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75K · Travel and Lodging: $11K · Consulting Fee: $7,000 · Food and Beverage: $4,726 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,680.00 |
| Travel and Lodging | $11,252.93 |
| Consulting Fee | $7,000.00 |
| Food and Beverage | $4,725.89 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $173,163.17 | 2019-2025 | Acuvue |
| Allergan, INC. | $5,714.02 | 2019-2022 | |
| Abbvie INC. | $2,048.40 | 2022-2025 | Vuity |
| Coopervision INC. | $249.61 | 2021-2023 | Myday Contact Lens |
| Topcon Healthcare, INC. | $163.21 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $149.04 | 2024 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $132.21 | 2022 | |
| Sun Pharmaceutical Industries INC. | $124.18 | 2022 | |
| Dompe US, INC. | $21.61 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.69 | 2019 | |
| Shire North American Group INC | $11.32 | 2019 | |
| Alcon Vision LLC | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyle Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.